MGNX
MACROGENICS INC
NASDAQ · Healthcare · Biotechnology · US
$2.31
−1.07%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 2.69x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 3.42x
- Price / sales
- 0.88x
- Price / cash flow
- -2.30x
Enterprise value
- Enterprise value
- $8.6M
- EV / sales
- 0.05x
- EV / EBITDA
- -0.11x
- EV / EBIT
- -0.21x
- Market cap
- $146.8M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026